A Guide to Maternal Health Before Conception
Learn MoreImagine two women, both planning to start a family. One struggles with her weight and has a family history of diabetes; the other is older than 35. Unbeknownst to them, both face an elevated risk of developing gestational diabetes mellitus (GDM) during pregnancy—a condition that can seriously impact both their health and their baby's future.
Gestational diabetes represents a growing health concern worldwide, affecting anywhere from 2% to over 20% of pregnancies depending on the population, with studies in Nigeria showing an incidence of 20.7% 7 .
The exciting frontier in maternal healthcare lies in early prediction and proactive preparation. Groundbreaking research is now making it possible to identify at-risk women before they even conceive, empowering them with knowledge and strategies to potentially change their health trajectory.
Gestational diabetes mellitus (GDM) is characterized by high blood glucose levels that first develop during pregnancy and typically resolve after childbirth. The condition arises from a perfect storm of hormonal changes: pregnancy hormones produced by the placenta interfere with the body's ability to use insulin effectively, creating a state of insulin resistance .
Women who experience GDM have a significantly elevated risk of developing type 2 diabetes in the subsequent 5-10 years . Emerging research also indicates that GDM serves as an early marker for future cardiovascular disease, with affected women showing higher rates of heart attacks, heart failure, and stroke decades after their pregnancy 4 .
While GDM can potentially affect any pregnant woman, certain factors significantly increase the risk. Understanding these risk factors helps identify who might benefit most from early screening and preconception interventions.
| Risk Factor Category | Specific Factors |
|---|---|
| Demographic Factors | Maternal age over 35 7 , Certain ethnicities (African American, Asian American, Hispanic, Native American, Pacific Islander) 3 |
| Weight & Metabolic Factors | Overweight or obesity (BMI ≥25) 7 , Polycystic ovary syndrome (PCOS) , Pre-existing high blood pressure 3 |
| Medical & Family History | Family history of type 2 diabetes 3 , Previous gestational diabetes in earlier pregnancy 3 , Previous birth of a child with congenital anomalies 7 |
| Current Pregnancy Factors | Multiple pregnancies (twins, triplets) 3 , Excessive weight gain during early pregnancy 1 |
The combination of age over 35 and obesity appears particularly significant. A 2025 study in Nigeria found that women 35 or older had a 48% higher risk of developing GDM, while obese women had an 85% increased risk 7 .
Traditionally, GDM is diagnosed between 24-28 weeks of gestation using an oral glucose tolerance test (OGTT) 1 . While effective, this timing limits opportunities for very early interventions. The holy grail of GDM prediction would identify at-risk women before or during early pregnancy—and recent research on circular RNAs (circRNAs) has made remarkable progress toward this goal.
CircRNAs are a unique class of RNA molecules characterized by their closed-loop structures, which make them exceptionally stable and resistant to degradation compared to linear RNAs 1 . This stability allows them to persist in bodily fluids like blood, making them ideal candidates as disease biomarkers.
Scientists have discovered that specific circRNAs show altered expression patterns in women who later develop GDM, suggesting they play a role in the underlying metabolic processes that lead to the condition.
A groundbreaking 2025 multicenter study by Ma et al. harnessed these properties to develop an early GDM prediction model 1 . The researchers used high-throughput sequencing to analyze blood samples from women in early pregnancy, identifying two specific circRNAs—hsa_circ_0031560 and hsa_circ_0000793—that were significantly elevated in women who later developed GDM.
| Performance Metric | Result |
|---|---|
| Area Under the Curve (AUC) | >0.90 |
| Sensitivity | High |
| Specificity | High |
| Sample Timing | Early and mid-gestation serum samples |
| Biomarkers Identified | hsa_circ_0031560 and hsa_circ_0000793 |
| Research Tool/Method | Function/Purpose |
|---|---|
| High-throughput RNA Sequencing | Allows comprehensive profiling of RNA molecules in blood samples to identify candidate circRNAs 1 |
| RNase R Treatment | Enzymatic treatment that degrades linear RNAs but not circular RNAs, helping to isolate and confirm circRNAs 1 |
| Quantitative RT-PCR with Divergent Primers | Specialized method to specifically detect and quantify circRNAs 1 |
| Logistic Regression Modeling | Statistical approach to develop predictive models that combine multiple biomarkers into a single risk score 1 |
| International Physical Activity Questionnaire (IPAQ) | Standardized tool for assessing pre-conception physical activity levels in risk assessment studies 2 |
For women identified as high-risk—whether through emerging biomarker tests or conventional risk factors—the period before conception offers a critical opportunity to reduce GDM likelihood. Medical organizations now strongly emphasize preconception care for all women with diabetes risk factors 5 9 .
The Endocrine Society and European Society of Endocrinology released joint guidelines in 2025 recommending that healthcare providers ask about pregnancy intention at every reproductive, diabetes, and primary care visit for women with diabetes or risk factors 9 .
Nutrition plays a crucial role in GDM prevention. While no single diet is universally prescribed, emphasis should be placed on a balanced eating pattern rich in vegetables, whole grains, lean proteins, and healthy fats .
For overweight or obese women, even modest weight loss (5-7% of body weight) before conception can significantly reduce GDM risk 3 . This should be pursued under medical supervision to ensure nutritional adequacy before pregnancy.
| Strategy | Specific Actions | Potential Benefit |
|---|---|---|
| Preconception Counseling | Discuss pregnancy intention with healthcare provider; review medical history and risk factors 5 9 | Identifies modifiable risks; allows for medication adjustments before conception |
| Dietary Modifications | Emphasize vegetables, whole grains, lean proteins; limit sugary foods and drinks; focus on carbohydrate quality and portion control | Improves insulin sensitivity; supports healthy weight; prevents blood sugar spikes |
| Physical Activity | Aim for at least 30 minutes of moderate activity most days (walking, swimming, stationary cycling) | Enhances insulin sensitivity; assists with weight management |
| Weight Management | Achieve healthy weight before conception; even 5-7% weight loss can significantly reduce risk if overweight 3 | Reduces underlying insulin resistance; decreases inflammatory burden |
Schedule preconception counseling, review medications, begin lifestyle modifications, achieve target weight if needed.
Early screening for high-risk women, continue healthy lifestyle, monitor weight gain.
Routine GDM screening for all pregnant women, intensified management if diagnosed.
Follow-up glucose testing, long-term cardiovascular risk monitoring, preparation for future pregnancies.
The landscape of gestational diabetes prediction and prevention is rapidly evolving. The emergence of molecular biomarkers like circRNAs promises a future where we can identify at-risk women with a simple blood test early in pregnancy or even before conception.
Meanwhile, advanced machine learning models are also showing remarkable accuracy in predicting GDM by analyzing clinical and demographic data 6 .
These technological advances, combined with growing recognition of the importance of preconception health, are transforming how we approach maternal wellbeing.
Rather than waiting to diagnose GDM in the second trimester, the medical community is moving toward a model of early risk assessment and proactive intervention.
The most powerful message for women contemplating pregnancy is that they are not passive recipients of their genetic or metabolic destiny. By understanding their personal risk factors, seeking preconception care, and adopting health-promoting behaviors before pregnancy, women can actively influence their pregnancy health outcomes.
As research continues to refine our predictive abilities and identify the most effective interventions, we move closer to a future where fewer women and their children face the short and long-term consequences of this common pregnancy complication.
Back to Top